Immunotherapy. 2011;3(10):1167-1184. Specifically, iNKT cells appear to inhibit early disease progression with their loss facilitating disease progression, while at later inflammatory stages, NKT ...
A next generation inducible armored CAR to overcome the immunosuppressive tumor microenvironment and enhances cytotoxicity of CAR-T and TILs. This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...